Market Access News | pharmaphorum

News

NICE says 'no' to Pfizer's Vyndaqel for rare heart condition

NICE has rejected regular NHS funding for Pfizer’s Vyndaqel (tafamidis) for a rare heart condition, although it has left the door open for negotiations if the pharma decid

News

Alvotech files lawsuit challenging AbbVie's Humira patent th...

Biosimilars firm Alvotech has filed a lawsuit that challenges AbbVie’s legal defences surrounding the inflammatory disease drug Humira in the US.

News

FDA authorises Pfizer/BioNTech vaccine for adolescents

The FDA has authorised Pfizer/BioNTech’s vaccine for 12- to 15 year-olds under emergency rules.

News

Scotland backs NHS use of Alexion's Ultomiris for rare disea...

NHS patients in Scotland with the rare disease atypical haemolytic uremic syndrome (aHUS) will now be able to access treatment with Alexion's Ultomiris, ahead of their counterparts in Engla

News

scientifically visualization of a coronavirus spike protein

EU starts rolling review of GSK's antibody for COVID-19

The EMA has begun a rolling review of a COVID-19 antibody developed by GlaxoSmithKline and Vir BioTech which could become the fourth drug of its type cleared for early use in the EU.

News

Pfizer shares slump as support grows for COVID-19 vaccine pa...

Shares in COVID-19 vaccine manufacturers have taken a hit after the US signalled its support for waiving patents on them, a move aimed to boost global supplies of the life-saving shots.

NICE says 'no' to Pfizer's Vyndaqel for rare heart condition

Alvotech files lawsuit challenging AbbVie's Humira patent th...

FDA authorises Pfizer/BioNTech vaccine for adolescents

Scotland backs NHS use of Alexion's Ultomiris for rare disea...

EU starts rolling review of GSK's antibody for COVID-19

Pfizer shares slump as support grows for COVID-19 vaccine pa...

On genomics, NGS, and doing much more good than bad, with Ma...

How to meet your physicians where they are online

News

Editor's Picks